Weekly Research Digest: Art Therapy Shows Promise in Clinical Trials and Lived Experience
This week Mad in America examines three studies around art therapy and art-based interventions for mental health issues.…
Novel lipid bubble delivery shows promise for ALS treatment
A researcher at the University of Missouri has made a promising breakthrough in the quest to help people…
New long-term analysis suggests follicular lymphoma can be cured
These findings could have long-reaching effects on patient care for people diagnosed with follicular lymphoma, Shadman said. “We…
Daily peanut butter intake boosts muscle power in older adults
A clinical trial by researchers at Deakin University’s Institute for Physical Activity and Nutrition (IPAN) in Melbourne, Australia,…
Psychedelic effects of ketamine do not predict sobriety
The psychedelic effects recreational users often seek from taking ketamine do not predict the therapeutic benefits for people…
Big breakfast study reveals protein curbs appetite but fiber delivers stronger gut microbiome benefits
A controlled clinical trial shows that what you eat at breakfast, not just how much, may shape appetite,…
High adherence and safety found in short TB treatments
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage…
Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation
New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in…
Cognitive speed training shows potential to delay dementia for two decades
Adults age 65 and older who completed five to six weeks of cognitive speed training – in this…
Intense exercise proves more effective for panic disorder treatment
Panic attacks are sudden bouts of intense fear without an obvious cause. An estimated 10% of people experience…
Novel neuroprotective drug improves recovery after acute ischemic stroke
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48…
Daily coffee intake linked to fewer atrial fibrillation relapses
A randomized trial suggests that avoiding coffee after cardioversion may not help, and that modest caffeine intake may…